Clinical trials on early detection of colorectal, prostate and breast cancers

Epiterapia Inc (Canada), the Institute of General Oncology and Cytology (Kazakhstan), Kazakh research institute of Oncology/Radiology (Kazakhstan) and HKGepitherapeutics (Honk Kong) signed the agreement on the beginning of clinical trials for early detection of colorectal, prostate and breast cancers with non-invasive method based on DNA methylation of circulated tumor DNA.

Epiterapia